Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada · Delayed Price · Currency is CAD 8.22
-0.64 (-7.22%)
Jul 24, 2026, 4:00 PM EST
Eupraxia Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Eupraxia Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $16.33. The average 1-year stock price forecast is 98.66% higher than the current stock price, while the lowest is $14.00 (+70.32%) and the highest is $18.00 (+118.98%).
Price Target: $16.33 (+98.66%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Eupraxia Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 9 | 9 | 10 | 11 | 11 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $35.06 | Buy | Reiterates | $35.06 | +326.57% | Jul 10, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $23.84 | Buy | Initiates | $23.84 | +190.07% | Jun 25, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $26.65 | Buy | Maintains | $26.65 | +224.19% | Jun 25, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $22.44 | Buy | Maintains | $22.44 | +173.00% | May 15, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $15.43 | Buy | Reiterates | $15.43 | +87.69% | May 14, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
9.99M
EPS This Year
-0.96
from -1.00
EPS Next Year
-0.88
from -0.96
EPS and Forward PE are based on non-GAAP adjusted numbers.